CD3 heterodimer: The signaling core of the T cell receptor complex and a key target for bispecific antibody development

Author: Senior Product Manager of UA Views：17

This article focuses on the molecular characteristics and biological functions of CD3 heterodimers, systematically elaborating the six-polypeptide chain composition of the CD3 protein complex and the structural organization of its three pairs of dimers (εγ, εδ, ζζ), analyzing the core roles of CD3εδ and CD3εγ heterodimers in ITAM signal transduction and T cell activation, and discussing the clinical application value of CD3 heterodimers as targets for bispecific antibody development.

Recent Advances
Product Information

Recent Advances

CD3 Heterodimers: The Signaling Core of the T Cell Receptor Complex and a Key Target for Bispecific Antibody Development

Brief Introduction: This article focuses on the molecular characteristics and biological functions of CD3 heterodimers, systematically describing the six-peptide chain composition of the CD3 protein complex and the structural organization of its three dimer pairs (εγ, εδ, ζζ), analyzing the core roles of CD3εδ and CD3εγ heterodimers in ITAM signal transduction and T cell activation, and discussing the clinical application value of CD3 heterodimers as targets for bispecific antibody development.

I. Overall Composition and Structural Organization of the CD3 Protein Complex.

The CD3 protein complex is composed of 6 peptide chains linked by non-covalent bonds. It is a single-pass transmembrane protein present on the surface of mature T cells, containing 3 dimer pairs (εγ, εδ, ζζ) and consisting of four invariant chains: CD3ε, CD3δ, CD3γ, and CD3ζ. This assembly pattern of six peptide chains and three dimer pairs constitutes the signaling framework of the TCR-CD3 complex. The N-terminal extracellular domain and transmembrane domain of CD3 proteins are highly conserved across all T cells. The N-terminal extracellular domain consists of two heterodimeric structural domains, CD3εγ and CD3εδ, while the transmembrane domain consists of a single homodimer, CD3ζζ. As the basic organizational unit of the extracellular domain, CD3 heterodimers determine the assembly mode of the CD3 complex with TCRαβ chains and the spatial configuration for ligand recognition.

II. Molecular Basis of CD3 Heterodimers and ITAM Signal Transduction.

The cytoplasmic region of CD3 contains immunoreceptor tyrosine-based activation motifs (ITAMs) essential for initiating the signaling cascade. As signal transduction intermediates and adaptor molecules, they are capable of recruiting protein tyrosine kinases. The cytoplasmic region of each CD3ε, CD3γ, and CD3δ subunit contains 1 ITAM, while the CD3ζ subunit contains 3 ITAMs. This ITAM distribution pattern means that CD3εδ and CD3εγ heterodimers each contribute two ITAMs, while the CD3ζζ homodimer contributes six ITAMs, totaling ten ITAMs that together form the signal amplification basis of the TCR-CD3 complex. When the TCR recognizes an antigen peptide-MHC complex, the ITAMs on each CD3 chain are phosphorylated by tyrosine kinases such as Lck, which in turn recruit downstream signaling molecules such as ZAP-70, initiating the cascade of T cell activation. The structural integrity of CD3 heterodimers is the molecular prerequisite for the normal progression of this signal transduction process.

III. Gene Encoding and Disease Association of CD3 Heterodimers.

CD3ε, CD3δ, CD3γ, and CD3ζ are encoded by the CD3E, CD3D, CD3G, and CD247 genes, respectively. These four encoding genes are located in the same cluster (q23) on human chromosome 11. This gene cluster arrangement suggests that CD3 subunits may share a common evolutionary origin and are subject to coordinated transcriptional regulation. Defects in CD3 subunits are typically associated with autoimmune diseases such as systemic lupus erythematosus. Among them, CD3ε is particularly important for T cell activation and development; once mutated, it may lead to severe combined immunodeficiency. These disease associations indicate that CD3 heterodimers are not only the structural basis of T cell signal transduction but also functionally critical nodes in immune system development and the maintenance of self-tolerance.

IV. Application of CD3 Heterodimers in Bispecific Antibody Development.

CD3 bispecific antibodies are capable of redirecting CD3-positive T cells to tumor sites and represent a highly promising immunotherapeutic strategy for treating hematological malignancies and solid tumors. CD3 is a transmembrane protein on the surface of T cells that can bind to the TCR on T cells to form a receptor complex and activate T cells. As a T cell engager, the two arms of a CD3 bispecific antibody can respectively bind to the CD3 antigen on the T cell surface and a tumor-associated antigen, guiding T cells to approach tumor cells and activating T cells to achieve tumor-killing functions. CD3 is currently a major target for global bispecific antibody drug development. CD3 molecules are widely distributed membrane antigens on the surface of mature T cells, combining with T cell antigen recognition receptors to form composite receptor molecules that activate T cells and achieve T cell redirection.

In the design of bispecific antibodies, precise simulation of the CD3 heterodimer conformation is a key technical step in antibody screening and activity evaluation. Since CD3ε exists physiologically as CD3εδ and CD3εγ heterodimers, using only the CD3ε single subunit protein makes it difficult to truly reflect the binding epitope and affinity characteristics of therapeutic antibodies. Therefore, high-quality recombinant CD3 heterodimer proteins have irreplaceable tool value for in vitro activity evaluation and molecular optimization of bispecific antibodies.

V. Conclusion.

In CD3-targeted drug development, high-quality heterodimer proteins are core tools for ensuring the reliability of antibody screening and activity evaluation. To meet the research and drug screening needs for CD3εδ heterodimers, UniA provides Biotinylated CD3 epsilon&CD3 delta Fc, His, Avi tag&Fc, Flag, Avi tagHeterodimer Protein, Human. This product employs a dual-tag design: the CD3ε subunit carries a His tag and an Avi tag, and the CD3ε subunit carries a Flag tag and an Avi tag. Heterodimer formation is driven by the Fc fragment, and site-specific biotinylation is achieved through biotin ligase. The combination of dual tags and biotinylation labeling enables the product to be detected via anti-His or anti-Flag antibodies, as well as to achieve highly sensitive immobilization and detection through the streptavidin system. This product is suitable for applications including binding activity analysis of CD3εδ heterodimers with TCR and therapeutic antibodies, in vitro screening and evaluation of CD3 bispecific antibodies, conformation-dependent epitope research of CD3 heterodimers, and exploration of T cell activation mechanisms.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Nanjing Univ is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UNIV Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next